Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
about
Can Aspirin and Cancer Prevention be Ageless Companions?Bifunctional Conjugates with Potent Inhibitory Activity Towards Cyclooxygenase and Histone DeacetylaseBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesNonsteroidal anti-inflammatory drugs and prostatic diseasesProstate Cancer and Aspirin Use: Synopsis of the Proposed Molecular MechanismsDerivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female Fish.EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
P2860
Q26827455-4FA24555-1440-4DA3-95EA-E5B3E4AA180AQ29248227-282A7AE8-EB47-46EA-98C4-DCEE25D2ED2CQ34132305-F45CFF8E-7A3A-4D3C-9279-17C58DE9D5A3Q38217858-51DAB7AE-992D-4FE7-B6FC-36C1551ED568Q38854428-35B01854-C30B-41A9-8BC5-438B13C614AAQ38959910-83FE15F2-B8AB-473C-B5A8-335F70983071Q39024826-85E5767B-97A5-4363-A5B9-5E5D884FB2B7Q40115428-09300166-CED4-43E9-9BA8-AB85EC607283Q50082353-3D62C3E1-B851-41CF-ACF2-3F9FB56D691CQ50128233-B84C0729-27EB-4BCF-91AA-7E7D5F8C3A1FQ55230010-E0307928-CD2E-472B-AC97-4D17A2444F7D
P2860
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@en
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@nl
type
label
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@en
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@nl
prefLabel
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@en
Prostaglandin receptor EP3 med ...... ance in prostate cancer cells.
@nl
P2093
P356
P1476
Prostaglandin receptor EP3 med ...... tance in prostate cancer cells
@en
P2093
Akira Yokomizo
Eiji Kashiwagi
Junichi Inokuchi
Momoe Itsumi
Seiji Naito
Takeshi Uchiumi
P304
P356
10.1530/ERC-12-0344
P577
2013-05-30T00:00:00Z